Banco Santander, S.A. (the "Bank" or "Banco Santander"), in compliance with the Securities Market legislation, hereby communicates the following:
OTHER RELEVANT INFORMATION
Reference is made to our notice of inside information of 4 February 2026 (official registry number 3077) (the "Buyback Commencement Communication"), relating to the buyback programme of own shares (the "Buyback Programme") approved by the Board of Directors of Banco Santander.
Pursuant to article 5 of Regulation (EU) no. 596/2014 on Market Abuse of 16 April 2014, and articles 2.2 and 2.3 of Commission Delegated Regulation (EU) 2016/1052, of 8 March 2016, the Bank informs of the transactions carried out over its own shares between 25 June and 1 July (both inclusive).
The cash amount of the shares purchased to 1 July 2026 as a result of the execution of the Buyback Programme amounts to 3,631,865,722 Euros, which represents approximately 72.2% of the maximum investment amount of the Buyback Programme. The programme was announced together with its other characteristics through the Buyback Commencement Communication. With these purchases, the Bank has repurchased approximately 17.3% of its outstanding shares as of 2021.
Date Security Transaction Trading venue Number of shares Weighted average price (€) | 25/06/2026 SAN Purchase XMAD 2,399,608 11.8104 | 26/06/2026 SAN Purchase XMAD 1,000,000 11.8331 | 29/06/2026 SAN Purchase XMAD 1,000,000 11.8812 | 30/06/2026 SAN Purchase XMAD 2,000,000 11.9783 | 01/07/2026 SAN Purchase XMAD 2,000,000 12.0302 | TOTAL 8,399,608 |
Issuer name: Banco Santander, S.A. - LEI 5493006QMFDDMYWIAM13
Reference of the financial instrument: ordinary shares - Code ISIN ES0113900J37
Detailed information of the transactions carried out within the referred period is attached as Annex I.
Boadilla del Monte (Madrid), 2 July 2026
ANNEX I
Detailed information on each of the transactions carried out within the context of the Buy-back Programme between 25/06/2026 and 01/07/2026 (both inclusive)
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy. END POSFLFIIDVIFIIR